Cited by 598Mitochondrial Function and PathologyAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record.

Cytochrome oxidase deficiency in Alzheimer’s disease

Parker, William Davis, Filley, Christopher M., Parks, Janice K.·1990·Neurology

DOI 10.1212/wnl.40.8.1302

Open this paper in CoChat — free account

Abstract

We assayed cytochrome oxidase and other electron transport chain activities in platelet mitochondria isolated from patients with Alzheimer's disease (AD). Five of 6 patients had striking reductions of platelet cytochrome oxidase activity (patient mean, 83.72 +/- 82.99 nmol/min/mg; control mean, 167.14 +/- 36.21 nmol/min/mg; n = 8). Other electron transport chain catalytic activities were not significantly different than control values. AD may be a systemic illness, a primary defect in cytochrome oxidase may be pathogenically important in its production, and the mitochondrial genes encoding cytochrome oxidase subunits may be important in producing the defect.

Integrity signals

Registry

Crossref · 10.1212/wnl.40.8.1302

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 301–400 of 597

A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer’s Disease Subjects: Results of a Single-Arm, Pilot Trial
Wilkins, H., Mahnken, J. D., Welch, P., Bothwell, R. J., Koppel, S. J., Jackson, R. L., Burns, J. M., & Swerdlow, R. H. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170077 · Cited by 51
“The raw COX Vmax was determined as a pseudo first order-rate constant (s−1/mg) by measuring the oxidation of reduced cytochrome c at 550 nm [3, 16].”
BackgroundMethod
Diseases resulting from mitochondrial DNA point mutations
Wallace, D. C., Lott, M. T., Shoffner, J. M., & Brown, M. D. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799605 · Cited by 51
Content and fatty acid composition of cardiolipin in the brain of patients with Alzheimer's disease.
Guan, Z.-Z., Söderberg, M., Sindelar, P., & Edlund, C. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90073-6 · Cited by 51
Mitochondrial DNA–Related Mitochondrial Dysfunction in Neurodegenerative Diseases
Swerdlow, R. H. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-0271-mdrmdi · Cited by 50
Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease
Reichmann, H., Fhirke, S., Hebenstreit, G. F., Schrubar, H., & Riederer, P. F. (1993) · Journal of Neurology · doi:10.1007/bf00839971 · Cited by 51
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Brinton, R. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 50
Bioenergetic medicine
Swerdlow, R. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12394 · Cited by 51
“Cytochrome oxidase (COX), pyruvate dehydrogenase complex (PDHC) and α-ketoglutarate dehydrogenase complex activities tend to run lower in AD subjects than they do in agematched control subjects (Parker et al., 1990; Gibson et al., 2010; Swerdlow, 2012b).”
Background
Neuropathology of synuclein aggregates
Duda, J. E., Lee, V. M. ‐., & Trojanowski, J. Q. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000715)61:2 · Cited by 263
Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
Wilkins, H., Carl, S. M., Greenlief, A. C. S., Festoff, B. W., & Swerdlow, R. H. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00311 · Cited by 51
“Several studies of rats have shown that inhibiting cytochrome oxidase (COX-IV) results in impaired long term potentiation, further demonstrating the importance of mitochondrial bioenergetic flux in memory and learning (Parker et al., 1990; Bennett et al., 1992; Swerdlow and Kish, 2002).”
Background
Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease
Duarte, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.044 · Cited by 49
Human Diseases with Defects in Oxidative Phosphorylation
Bentlage, H., de Coo, I. F. M., Laak, H. T., Sengers, R. C. A., Trijbels, F. J. M., Ruitenbeek, W., Schlote, W., Pfeiffer, K., Gencic, S., von JAGOW, G., et al. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0909p.x · Cited by 48
Infusion of Plasma from Exercised Mice Ameliorates Cognitive Dysfunction by Increasing Hippocampal Neuroplasticity and Mitochondrial Functions in 3xTg-AD Mice
Kim, T.-W., Park, S.-S., Park, J., & Park, H.-S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093291 · Cited by 48
“It has been suggested that mitochondrial dysfunction could develop when the course of AD worsens or in all stages of the disease, and that this process may occur not only in the brain, but systemically [13].”
Background
Overexpression of manganese superoxide dismutase attenuates neuronal death in human cells expressing mutant (G37R) Cu/Zn‐superoxide dismutase
Flanagan, S. W., Anderson, R. D., Ross, M. A., & Oberley, L. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00812.x · Cited by 47
“Despite recent evidence implicating oxidative stress in Alzheimer’s (Parker et al. 1990; Pappolla et al. 1992) and Parkinson’s disease (Swerdlow et al. 1996), to date there are limited analyses of mitochondrial function in ALS.”
Background
Assessment of Platelet Respiration as Emerging Biomarker of Disease
Petruş, A., Lighezan, D. L., Dănilă, M. D., Duicu, O., Sturza, A., Muntean, D. M., & Ioniță, I. (2019) · Physiological Research · doi:10.33549/physiolres.934032 · Cited by 47
“…as a very useful, minimally invasive diagnostic and prognostic tool in widespread pathologies proven to affect mitochondrial complexes III and IV, such as diabetes (Raza et al. 2011), Alzheimer’s disease (Parker et al. 1990b) or Parkinson’s disease (Benecke et al. 1993, Haas et al. 1995).”
Background
Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing
Coon, K. D., Valla, J., Szelinger, S., Schneider, L. E., Niedzielko, T. L., Brown, K. M., Pearson, J. V., Halperin, R. F., Dunckley, T. L., Papassotiropoulos, A., et al. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.07.002 · Cited by 47
Genetic basis of Alzheimer's dementia: role of mtDNA mutations
Grazina, M. M., Pratas, J., Silva, F., Oliveira, S. A., Santana, I. J., & Oliveira, C. R. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00225.x · Cited by 47
Carnosic Acid as a Promising Agent in Protecting Mitochondria of Brain Cells
de Oliveira, M. R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0842-6 · Cited by 46
“[86] have described impaired complex IV in the platelets isolated from”
Background
Neurodegenerative ‘overlap’ syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease
Uitti, R. J., Berry, K., Yasuhara, O., et al. (1995) · Parkinsonism & Related Disorders · doi:10.1016/1353-8020(95)00004-p · Cited by 45
Mitochondrial medicine and the neurodegenerative mitochondriopathies
Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43
“The most specific defect involves a reduction in the complex IV (cytochrome oxidase) Vmax activity [6].”
Background
Amyloid precursor protein‐mediated mitochondrial regulation and Alzheimer's disease
Lopez Sanchez, M. I. G., van Wijngaarden, P., & Trounce, I. A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14554 · Cited by 45
Differential expression of cytochrome oxidase (COX) genes in different regions of monkey brain
Chandrasekaran, K., Stoll, J., Giordano, T., Atack, J. R., Matocha, M. F., Brady, D. R., & Рапопорт, С. И. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320313 · Cited by 44
Effects of aging on numbers and sizes of neurons in histochemically defined subregions of monkey striate cortex
Kim, C. B. Y., Pier, L. P., & Spear, P. D. (1997) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199701)247:1 · Cited by 42
No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant
Wragg, M. A., Talbot, C. J., Morris, J. C., Lendon, C. L., & Goate, A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12146-3 · Cited by 44
Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta
Lopez Sanchez, M. I. G., Waugh, H. S., Tsatsanis, A., Wong, B. X., Crowston, J. G., Duce, J. A., & Trounce, I. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-10233-0 · Cited by 45
Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients
Gonzalez-Lima, F., Valla, J. E., & Matos-Collazo, S. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01464-3 · Cited by 43
Chronic sodium azide treatment impairs learning of the Morris water maze task
Bennett, M. C., & Rose, G. M. (1992) · Behavioral and Neural Biology · doi:10.1016/0163-1047(92)90967-9 · Cited by 43
Protective Effect of Bajijiasu Against β-Amyloid-Induced Neurotoxicity in PC12 Cells
Chen, D., Zhang, P., Lin, L., Shuai, O., He-Ming, Z., Liu, S., & Wang, J.-Y. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9950-7 · Cited by 42
“Mitochondrial dysfunction has been demonstrated in cells treated with Ab (Zhang et al. 2008), AD transgenic mice (Eckert et al. 2008), platelets from AD patients (Parker et al. 1990), and in postmortem brains of AD Fig.”
Background
Is ammonia a pathogenetic factor in Alzheimer's disease?
Seiler, N. (1993) · Neurochemical Research · doi:10.1007/bf00969079 · Cited by 40
Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: Correlations with behavior and oxidative stress
Strazielle, C., Jazi, R., Verdier, Y., Qian, S., & Lalonde, R. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.08.005 · Cited by 43
Effects of treadmill exercise on mitochondrial fusion and fission in the hippocampus of APP/PS1 mice
Yan, Q.-W., Zhao, N., Xia, J., Li, B., & Yin, L. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.030 · Cited by 44
Mitochondrial Dysfunction in Alzheimer’s Disease and Progress in Mitochondria-Targeted Therapeutics
Flannery, P. J., & Trushina, E. V. (2019) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-019-00179-0 · Cited by 41
Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts
Swerdlow, R. H., Hui, D., Chalise, P., Sharma, P., Wang, X., Andrews, S. J., Pa, J., Mahnken, J. D., Morris, J. K., Wilkins, H., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12119 · Cited by 39
Cerebrospinal fluid pyruvate levels in Alzheimer’s disease and vascular dementia
Parnetti, L., Reboldi, G., & Gallai, V. (2000) · Neurology · doi:10.1212/wnl.54.3.735 · Cited by 40
Electrophoretic separation of multiprotein complexes from blood platelets and cell lines: Technique for the analysis of diseases with defects in oxidative phosphorylation
Schägger, H., Bentlage, H., Ruitenbeek, W., Pfeiffer, K., Rotter, S., Rother, C., Böttcher‐Purkl, A., & Lodemann, E. (1996) · Electrophoresis · doi:10.1002/elps.1150170415 · Cited by 39
Energy, oxidative damage, and Alzheimer's disease: Clues to the underlying puzzle
Beal, M. F. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90198-8 · Cited by 38
Feature Selection for Alzheimer’s Gene Expression Data Using Modified Binary Particle Swarm Optimization
Ramaswamy, R., Premalatha, K., & Swathypriyadharsini, P. (2021) · IETE Journal of Research · doi:10.1080/03772063.2021.1962747 · Cited by 39
Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
Zubenko, G. S. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709000303 · Cited by 37
Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: “Use it and lose it”
Greenamyre, J. T. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90012-9 · Cited by 37
31P magnetic resonance spectroscopy in alzheimer's and pick's disease
Smith, C. D., Gallenstein, L. G., Layton, W. J., Kryscio, R. J., & Markesbery, W. R. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90026-8 · Cited by 37
Peripheral adenosine levels in euthymic patients with bipolar disorder
Gubert, C., Moritz, C. E. J., Vasconcelos-Moreno, M. P., Tietbohl-Santos, B., Sartori, J., Fijtman, A., Kauer‐Sant’Anna, M., Kapczinski, F. P., Battastini, A. M. O., & Magalhães, P. V. D. S. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.007 · Cited by 36
Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations
Keil, U., Hauptmann, S., Bonert, A., Scherping, I., Eckert, A., & Müller, W. E. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9206 · Cited by 36
An optimized method for determining cytochrome oxidase activity in brain tissue homogenates
Hevner, R. F., Liu, S., & Wong‐Riley, M. T. T. (1993) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(93)90038-s · Cited by 36
Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases
H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35
“A systemic cytochrome oxidase defect was described in AD subjects, and the importance of this defect was emphasized through studies in which cytochrome oxidase inhibition was found to impair long term potentiation in rats [8, 38, 43].”
Background
Schisandrin B as a Hormetic Agent for Preventing Age-Related Neurodegenerative Diseases
Lam, P. Y., & Ko, K. M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/250825 · Cited by 35
“Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2012, Article ID 250825, 9 pages doi:10.1155/2012/250825”
Influential
Bioenergetics and metabolism: a bench to bedside perspective
Swerdlow, R. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13509 · Cited by 35
New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34
“One study found reduced COX activity in AD subject platelets, but no significant effects were observed for other ETC complexes including Complex I and Complex II [16].”
Background
Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
Trushina, E. V. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.06.008 · Cited by 35
“In 1990, Parker and colleagues reported decreased cytochrome oxidase (COX) activity indicative of mitochondrial dysfunction in platelets from AD subjects [53].”
Background
Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice
Shang, Y., Mishra, A., Wang, T., Wang, Y., Desai, M. K., Chen, S., Mao, Z., Do, L., Bernstein, A. S., Trouard, T. P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0225392 · Cited by 36
Characterization of Cybrid Cell Lines Containing mtDNA from Huntington's Disease Patients
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Shilling, A. T., Bennett, J. P., Harrison, M. B., & Parker, W. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1095 · Cited by 35
Self-citation
Mitochondrial DNA and Disease
Suomalainen, A. (1997) · Annals of Medicine · doi:10.3109/07853899708999341 · Cited by 38
Moderate and Advanced Alzheimer’s Patients Exhibit Platelet Activation Differences
Davies, T. A., Long, H. J., Tibbles, H. E., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00016-x · Cited by 35
Uridine Prodrug Improves Memory in Tg2576 and TAPP Mice and Reduces Pathological Factors associated with Alzheimer's Disease in Related Models
Saydoff, J. A., Olariu, A., Sheng, J. G., Hu, Z., Li, Q., Garcia, R. A. G., Pei, J., Sun, G. Y., & von Borstel, R. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130059 · Cited by 36
“There is a robust deficiency in the activity of cytochrome c oxidase in the brains of patients with sporadic AD [83].”
Background
Alzheimer's Proteins, Oxidative Stress, and Mitochondrial Dysfunction Interplay in a Neuronal Model of Alzheimer's Disease
Bobba, A., Petragallo, V. A., Marra, E., & Atlante, A. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/621870 · Cited by 36
Coenzyme Q10, iron, and vitamin B6 in genetically-confirmed Alzheimer's disease
Imagawa, M., Naruse, S., Tsuji, S., Fujioka, A., & Yamaguchi, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)92203-r · Cited by 34
The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer’s Disease Pathology
Jové, M., Mota‐Martorell, N., Torres, P., Ayala, V., Portero‐Otín, M., Ferrer, I., & Pamplona, R. (2021) · Life · doi:10.3390/life11050388 · Cited by 31
Polymorphic variation in cytochrome oxidase subunit genes
Lu, J., Wang, K., Rodova, M., Esteves, R., Berry, D., E, L., Crafter, A., Barrett, M., Cardoso, S. M., Onyango, I., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100123 · Cited by 33
“For studies providing control subject COX activity scatter plots the highest values may exceed the lowest values by over 100% [8,14,15].”
Self-citation
Extraneuronal Manifestations of Alzheimer's Disease
Scott, R. B. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb06704.x · Cited by 33
Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer’s Disease: A Critical Review of New and Old Little Regarded Findings
Atlante, A., & Valenti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115951 · Cited by 33
Alzheimer disease as a vascular disorder: Where do mitochondria fit?
Correia, S. C., Santos, R. X., Cardoso, S., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.006 · Cited by 32
Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration
Pacini, N., & Borziani, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030341 · Cited by 33
Mitochondrial DNA Manipulations Affect Tau Oligomerization
Weidling, I. W., Wilkins, H., Koppel, S. J., Hutfles, L. J., Wang, X., Kalani, A., Menta, B. W., Ryan, B. J., Ortiz, J. P., Gamblin, T. C., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200286 · Cited by 31
Mitochondrial Function and Alzheimer’s Disease
Ojaimi, J., & Byrne, E. (2001) · Neurosignals · doi:10.1159/000046890 · Cited by 32
Glutathione Cycle Impairment Mediates Aβ-induced Cell Toxicity
Cardoso, S. M., & Oliveira, C. R. (2003) · Free Radical Research · doi:10.1080/1071576021000041023 · Cited by 32
Oxidative Stress and Alzheimer’s Disease
Singh, S. K., Castellani, R. J., & Perry, G. L. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_10 · Cited by 33
“In addition, Aβ also hinders α-ketoglutarate dehydrogenase activity in isolated mitochondria [69], causes shortage of α- cytochrome oxidase activities [70] and ketoglutarate dehydrogenase [71], and has previously been found in the brain and other tissues of AD patients.”
Background
Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex of the monkey brain: correlation with specific neuronal pathways
Chandrasekaran, K., Stoll, J., Brady, D. R., & Rapoport, S. I. (1992) · Brain Research · doi:10.1016/0006-8993(92)90070-p · Cited by 32
Effects of memantine on mitochondrial function
McAllister, J., Ghosh, S., Berry, D., Park, M., Sadeghi, S., Wang, K. X., Parker, W. D., & Swerdlow, R. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.019 · Cited by 30
Self-citation
Understanding the role of OXPHOS dysfunction in the pathogenesis of ECHS1 deficiency
Burgin, H. J., & McKenzie, M. (2020) · FEBS Letters · doi:10.1002/1873-3468.13735 · Cited by 32
Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer’s Disease
Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 31
Changes of mitochondrial cytochrome c oxidase and FoF1 ATP synthase subunits in rat cerebral cortex during aging
Nicoletti, V. G., Tendi, E. A., Lalicata, C., Reale, S., Costa, A., Villa, R. F., Ragusa, N., & Stella, A. M. G. (1995) · Neurochemical Research · doi:10.1007/bf00970595 · Cited by 31
Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy
Maszka, P., Kwaśniak-Butowska, M., Cysewski, D., Sławek, J. W., Smolenski, R. T., & Tomczyk, M. (2023) · Metabolites · doi:10.3390/metabo13030369 · Cited by 32
The multifaceted role of quercetin derived from its mitochondrial mechanism
Carrillo-Garmendia, A., Pérez, L. A. M., & Regalado‐González, C. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04833-w · Cited by 36
“For example, platelet mitochondria isolated from Alzheimer's patients showed decreased complex IV activity (dependent on oxidation of reduced cytochrome c ) [58, 66].”
Unravelling protein aggregation as an ageing related process or a neuropathological response
Trigo, D., Nadais, A., & Silva, O. A. B. D. C. E. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.02.001 · Cited by 31
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients
Vidoni, E. D., Choi, I., Lee, P., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12156 · Cited by 30
Mitochondrial Disorders in Alzheimer’s Disease
Sukhorukov, V. S., Mudzhiri, N. M., Voronkova, A. S., Baranich, T. I., Glinkina, V. V., & Illarioshkin, S. N. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921060055 · Cited by 30
Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer’s Disease
Ridge, P. G., Koop, A., Maxwell, T. J., Bailey, M. H., Swerdlow, R. H., Kauwe, J. S. K., Honea, R. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074158 · Cited by 30
Platelet biomechanics, platelet bioenergetics, and applications to clinical practice and translational research
George, M. J., Bynum, J. A., Nair, P. M., Cap, A. P., Wade, C. E., Cox, C. S., & Gill, B. S. (2018) · Platelets · doi:10.1080/09537104.2018.1453062 · Cited by 29
Increased susceptibility of copper-deficient neuroblastoma cells to oxidative stress-mediated apoptosis
Rossi, L. C., Marchese, E., Lombardo, M. F., Rotilio, G., & Ciriolo, M. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00533-0 · Cited by 28
Regional brain cytochrome oxidase activity in β-amyloid precursor protein transgenic mice with the swedish mutation
Strazielle, C., Sturchler, C., Staufenbiel, M., & Lalonde, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00037-x · Cited by 31
Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle
Morris, J. K., McCoin, C. S., Fuller, K. N. Z., John, C. S., Wilkins, H., Green, Z. D., Wang, X., Sharma, P., Burns, J. M., Vidoni, E. D., et al. (2021) · Function · doi:10.1093/function/zqab045 · Cited by 26
Mitochondrial mechanisms in Alzheimer’s disease: Quest for therapeutics
Kalani, K., Chaturvedi, P., Chaturvedi, P., Verma, V. K., Lal, N., Awasthi, S. K., & Kalani, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103547 · Cited by 28
Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease
Saydoff, J. A., Garcia, R. A. G., Browne, S. E., Liu, L., Sheng, J. G., Brenneman, D., Hu, Z., Cardin, S., González, A., von Borstel, R. W., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.011 · Cited by 28
Mitophagy in Neurodegeneration: An Opportunity for Therapy?
Santos, R. X., Correia, S. C., Carvalho, C., Cardoso, S., Santos, M. S., & Moreira, P. I. (2011) · Current Drug Targets · doi:10.2174/138945011795528813 · Cited by 29
Effects of acidosis on the distribution and processing of the β-amyloid precursor protein in cultured hippocampal neurons
Brewer, G. J. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815241 · Cited by 28
“…by feedback inhibition from the reported 60% AD decrement in downstream brain ketoglutarate dehydrogenase complex activity (Gibson et al., 1988) and the 50% AD decrement in brain oxidative phosphorylat ion at cytochrome oxidase (Parker et al., 1990; Simonian and Hyman, 1993; Parker et al., 1994).”
Background
Mitochondrial dysfunction and Alzheimer's disease: New developments
Mancuso, M., Siciliano, G., Filosto, M., & Murri, L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9203 · Cited by 28
Vulnerability of neurons with mitochondrial dysfunction to oxidative stress is associated with down-regulation of thioredoxin
Gao, J., Zhu, Z., Ding, H., Qian, Z., Zhu, L., & Ke, Y. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.007 · Cited by 27
Platelet Protein Kinase C levels in Alzheimer's disease
Matsushima, H., Shimohama, S., Tanaka, S., Taniguchi, T., Hagiwara, M., Hidaka, H., & Kimura, J. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90047-7 · Cited by 26
Pathogenic role of mitochondrial amyloid-β peptide
Chen, J. X., & Yan, S. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1517 · Cited by 26
Inherent Abnormalities in Oxidative Metabolism in Alzheimer's Disease: Interaction with Vascular Abnormalities
Blass, J. P., Sheu, K. R., Piacentini, S., & Sorbi, S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48488.x · Cited by 27
Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?
Rottkamp, C. A., Nunomura, A., Hirai, K., Sayre, L. M., Perry, G. L., & Smith, M. A. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00124-x · Cited by 27
The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years.
Tysoe, C. J., Robinson, D., Brayne, C., Dening, T., Paykel, E. S., Huppert, F. A., & Rubinsztein, D. C. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.12.1002 · Cited by 26
Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer’s dementia
Amick, K. A., Mahapatra, G., Gao, Z., DeWitt, A. R., Craft, S., Jain, M., & Molina, A. J. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.954090 · Cited by 27
“Compared to healthy controls, platelets from patients with AD have decreased cytochrome oxidase activity (Parker et al., 1990; Parker et al., 1994).”
Background
Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer’s disease
Wasim, R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01916-6 · Cited by 31
“It was also shown that AD patients lacked the enzymes pyruvate dehydrogenase and cytochrome oxidase (Parker et al. 1990; Sorbi et al. 1983; Rex et al. 1985).”
Heat therapy: possible benefits for cognitive function and the aging brain
Schulze, A. T. V., Deng, F., Morris, J. K., & Geiger, P. C. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00168.2020 · Cited by 26
Systematic review of 31P-magnetic resonance spectroscopy studies of brain high energy phosphates and membrane phospholipids in aging and Alzheimer's disease
Jett, S., Boneu, C., Zarate, C., Carlton, C., Kodancha, V., Nerattini, M., Battista, M., Pahlajani, S. S., Williams, S., Dyke, J. P., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1183228 · Cited by 30
“31P-MRS imaging allows measurement of ATP formation from adenosine diphosphate (ADP) and Pi in mitochondria, which occurs primarily through OXPHOS catalyzed by the enzyme ATP synthase (ATPsyn) (Boyer, 1999).”
BackgroundInfluential
The role of calcineurin in amyloid-β-peptides-mediated cell death
Cardoso, S. M., & Oliveira, C. R. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.078 · Cited by 26
What Is Primary and What Secondary for Amyloid Deposition in Alzheimer's Disease
Meier‐Ruge, W., Iwangoff, P., & Bertoni–Freddari, C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56831.x · Cited by 27
The "new" mitochondrial disorders
Schapira, A. H. V. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.144 · Cited by 26
Mitochondrial DNA and genetic disease
Poulton, J. (1992) · BioEssays · doi:10.1002/bies.950141108 · Cited by 61
Effect of β-amyloid on blood-brain barrier properties and function
Petrushanko, I. Y., Mitkevich, V. A., & Makarov, A. А. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01052-x · Cited by 28
“activity of mitochondrial complexes IV and I in the brain tissue of AD patients (Parker et al. 1990; Parker et al. 1994).”
Background
The Neuroprotective Effects of Decursin Isolated from Angelica gigas Nakai Against Amyloid β-Protein-Induced Apoptosis in PC 12 Cells via a Mitochondria-Related Caspase Pathway
Li, L., Du, J., Zou, L., Xia, H., Wu, T., Kim, Y.-H., & Lee, Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1623-0 · Cited by 26

Authors: Parker, W. D., Filley, C. M., & Parks, J. K.
Affiliations: University of Colorado Denver (US)
ORCID: Filley, Christopher M.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 40
Issue: 8
Pages: 1302-1302
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.40.8.1302
OpenAlex: W1988731658
Cited by: 598
References: 0
Citations by year: 2026: 19 · 2025: 10 · 2024: 12 · 2023: 20 · 2022: 9 · 2021: 22 · 2020: 25 · 2019: 19 · 2018: 18 · 2017: 18 · 2016: 28 · 2015: 10 · 2014: 10 · 2013: 21 · 2012: 15
FWCI: 7.27
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (7r01ns025382-06)
National Institute of Neurological Disorders and Stroke (NS25382)
National Center for Research Resources (RR-69)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: cytochrome oxidase deficiency, Alzheimer's disease, platelet mitochondria, electron transport chain, mitochondrial dysfunction, systemic disease
MeSH terms: Aged, Alzheimer Disease, Blood Platelets, Electron Transport Complex IV, Electron Transport, Female, Humans, Kinetics, Male, Mitochondria, Reference Values, Cytochrome-c Oxidase Deficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytochrome oxidase deficiency in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks